US · MTSR
Metsera, Inc.
- Sector
- Healthcare · Biotechnology
- Headquarters
- New York City, NY 10007
- Website
- metsera.com
Price at previous close
$70.50
Market cap 7.5B
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 |
USD millions
Line items
USD millions
Line items
USD millions
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | Model Valuation | Core Valuation | Growth | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| MTSR | Metsera, Inc. | $70.50 | 7.5B | — | — | — | — | — | — | — | — | — |
| ABVX | Abivax S.A. | $99.61 | 7.53B | -59% | -97% | — | — | -2.42 | 10.50 | 39.48 | -2.21 | 13354.00% |
| ACLX | Arcellx, Inc. | $87.51 | 4.85B | -25% | — | — | — | -28.05 | — | — | -31.38 | -10000.00% |
| ARWR | Arrowhead Pharmaceuticals… | $40.31 | 5.57B | +8,781% | -36% | -92% | — | 272.90 | 17.63 | 9.91 | 46.50 | 2325815.00% |
| AXSM | Axsome Therapeutics, Inc. | $135.69 | 6.84B | -26% | +7,385% | — | — | -45.19 | 93.74 | 12.96 | -48.76 | 6555.00% |
| CRSP | CRISPR Therapeutics AG | $56.99 | 5.18B | -36% | -43% | — | +785% | -9.40 | 2.84 | 1556.91 | -7.08 | -8997.00% |
| CYTK | Cytokinetics, Incorporate… | $59.19 | 7.08B | +1% | -56% | — | — | -9.39 | -11.18 | 83.75 | -10.03 | 37656.00% |
| MRUS | Merus N.V. | $95.18 | 7.22B | -63% | -77% | — | -87% | -13.74 | 4.57 | 84.83 | -9.34 | -1238.00% |
| NUVL | Nuvalent, Inc. | $92.09 | 6.7B | — | — | — | — | -17.31 | 5.90 | — | -571.33 | — |
| PCVX | Vaxcyte, Inc. | $40.32 | 5.23B | — | — | — | — | -11.00 | 3.14 | — | -9.58 | — |
| RYTM | Rhythm Pharmaceuticals, I… | $99.47 | 6.61B | -41% | +4,432% | — | — | -31.39 | 44.36 | 32.51 | -33.22 | 4583.00% |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $70.50) − 1 = — (DCF, example).